About this trial
The purpose of this 2-site (CT, AL) study is to test innovative interventions to reduce stigma and improve the pre-exposure prophylaxis (PrEP) and opioid use disorder (OUD) care continua in women involved in the criminal justice system (WICJ).
This study evaluates a newly validated PrEP decision aid and eHealth for integrated PrEP and MOUD compared to a decision aid-only for WICJ with OUD.
Eligibility criteria
Qualifiers
woman
have access to a working mobile or landline phone
Lifetime CJ-involvement (probation, parole, intensive pretrial or community supervision, or release from prison/jail)
are confirmed HIV-negative by point-of-care 3rd generation HIV antibody test
Disqualifiers
unable or unwilling to provide informed consent
pregnant or breast-feeding
currently taking PrEP at the time of study enrollment
not comfortable conversing in English or Spanish.
Trial design
Treatments tested in this trial
- Decision Aid
- Athena strategy
Treatment groups
Sponsors and collaborators
Yale University
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator